Rac-2-Phenoxy-1-Phenylethanol Synthesis Route Manufacturing Process
- [Reaction Kinetics]: Optimized etherification pathways ensure consistent yields and minimized side-product formation during scale-up.
- [Supply Chain]: Factory-direct procurement guarantees tonnage quantities with stable lead times and competitive bulk pricing structures.
- [Compliance Status]: Adherence to international regulatory standards ensures suitability for pharmaceutical and fine chemical applications.
In the landscape of fine chemical intermediates, precise control over the manufacturing process is critical for downstream application success. Rac-2-Phenoxy-1-Phenylethanol (CAS: 4249-72-3) serves as a vital building block in organic synthesis, particularly valued for its utility as a lignin model compound and a specialized intermediate in pharmaceutical development. As demand for process-scale purity increases, manufacturers must prioritize robust synthesis routes that minimize impurities such as unreacted phenols or isomeric by-products.
NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer dedicated to delivering this complex intermediate with rigorous quality assurance. By leveraging advanced reaction engineering and purification technologies, we ensure that every batch meets the stringent requirements of R&D laboratories and industrial production lines alike. This technical overview details the synthesis methodologies, quality control parameters, and safety protocols essential for sourcing this material at scale.
Scalable Organic Synthesis Pathways Overview
For process chemists, the selection of a viable synthesis route determines the economic feasibility and purity profile of the final product. The production of rac-2-phenoxy-1-phenylethanol typically involves the nucleophilic opening of epoxide rings or etherification reactions under controlled conditions. Industrial best practices dictate maintaining reaction temperatures within a moderate range to prevent thermal degradation while maximizing conversion rates.
Key considerations for the organic synthesis of this compound include:
- Catalyst Selection: Utilizing alkaline catalysts or specific phase-transfer agents to enhance reaction kinetics without introducing difficult-to-remove metal residues.
- Impurity Management: Monitoring for the formation of condensation by-products, such as di-ether derivatives, which can comp downstream purification.
- Yield Optimization: Implementing dropwise addition protocols for reactants to maintain selectivity toward the mono-derivative, ensuring theoretical yields exceed 75% in production-scale batches.
Advanced manufacturing facilities employ in-process controls to monitor reaction progress, ensuring that the profile of 2-Phenoxy-1-phenyl-ethanol remains consistent across different production runs. This level of control is essential for maintaining batch-to-batch consistency, a critical factor for clients integrating this intermediate into multi-step synthesis pipelines.
Quality Control in Manufacturing Process Steps
Procurement specialists prioritize verification of industrial purity and documentation when sourcing chemical intermediates. The purification stage is as critical as the reaction itself. Following the initial synthesis, the crude product undergoes fractional distillation under reduced pressure. This step is vital for separating the target compound from unreacted starting materials, such as phenol, which may sublime under standard distillation conditions.
To meet pharmaceutical-grade standards, residual phenol content must often be restricted to less than 0.10% w/w. Our quality assurance teams utilize high-performance liquid chromatography (HPLC) and gas chromatography (GC) to verify these limits. When sourcing high-purity 2-Phenoxy-1-phenylethanol, buyers should request a batch-specific Certificate of Analysis (COA) that details impurity profiles and physical constants.
The following table outlines typical technical specifications for commercial-grade supply:
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Colorless to Pale Yellow Liquid | Visual Inspection |
| Purity (GC) | ≥ 98.0% | Gas Chromatography |
| Phenol Content | ≤ 0.10% w/w | HPLC / GC-MS |
| Water Content | ≤ 0.5% | Karl Fischer Titration |
| CAS Number | 4249-72-3 | N/A |
Strict adherence to these parameters ensures the material is suitable for sensitive applications where trace impurities could affect catalyst performance or final product safety. Our manufacturing process is designed to consistently meet these specifications, providing reliability for long-term supply contracts.
Safety Protocols for Large-Scale Production
For executives evaluating commercial viability, regulatory compliance and operational safety are paramount. Large-scale production of ether-alcohols requires adherence to strict safety protocols regarding handling, storage, and transport. Facilities must be equipped to manage potential hazards associated with alkaline catalysts and organic solvents used during extraction phases.
As a leading global manufacturer, we ensure all production sites comply with relevant environmental and safety regulations, including REACH and TSCA guidelines where applicable. This compliance mitigates supply chain risk for international buyers. Furthermore, optimizing the bulk price of intermediates involves not only raw material costs but also the efficiency of waste management and solvent recovery systems.
Investing in a supply partner with robust safety infrastructure protects your organization from regulatory disruptions. We maintain comprehensive Safety Data Sheets (SDS) for all shipments, ensuring that your logistics and safety teams have the necessary information for compliant handling upon receipt.
To secure a reliable supply of this critical intermediate, we invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting your production goals with high-quality chemicals and unmatched service reliability.